Menu
Search Close

News

Director Share Dealing

21st October 2013

The Company has been notified that on 21 October 2013 Lindy Durrant and Richard Goodfellow each sold 100,000 shares in the Company from their respective holdings held jointly with Scancell Employee Benefit Trust at a price of 30 pence per share.

Following these transactions their holdings in the Company are as follows:

 

Director Name

No. of shares held in own sole name post transaction

 

No. of shares held jointly with Scancell Employee Benefit Trust post transaction

 

Lindy Durrant

1,606,960

 

8,773,960

Richard Goodfellow

200,000

 

6,343,840

 

For Further Information:

 

Scancell Holdings Plc 

+ 44 (0) 20 7831 3113 

Dr Richard Goodfellow, Joint CEO 

 

Professor Lindy Durrant, Joint CEO 

 

 

 

Cenkos Securities plc:

+44 (0) 20 7397 8900

Camilla Hume

 

Stephen Keys

 

 

 

FTI Consulting

+44 (0) 20 7831 3113

Simon Conway

 

Mo Noonan

 

 

 

Dr. Reuter Investor Relations

+(0) 49 251 980 1561

Kim von Ahn

 

Webcasts, Interviews and Media Coverage

Scancell Holdings lays groundwork for pivotal year

A £3.9mln injection from the life sciences fund Vulpes will effectively bankroll the latest R&D

Tue, 20 Aug 2019 06:05:00

Scancell to begin UK arm of phase II skin cancer trial ‘immediately’

Discussions with US regulators have taken longer than expected, so Scancell will now focus its efforts on completing the UK arm of the trial before re-submitting its US application at a later date

Mon, 19 Aug 2019 06:46:00